Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Investors should watch its Phase 3 readouts, regulatory filing timeline, adverse event profile, discontinuation rates, and performance in patients with comorbidities such as sleep apnea, diabetes, osteoarthritis, cardiovascular risk, and liver disease
Safe and Comfortable Care At Simple IV, your safety comes first
Wirth JJ, Fraker PJ, Kierszenbaum F
Many users report increased energy, improved skin clarity, and enhanced resilience within the first few weeks of regular injections
Reported biochemical potency against human NNMT is in the low-micromolar range with cellular EC values in the low-micromolar range for suppression of 1-MNA and lipogenesis, with selectivity over related methyltransferases and NAD-salvage enzymes [1,6,7]
US$ 21.37
US$ 23.20
US$ 29.90
